Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
RAS wild-type
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3845
;
4893
;
3265
Related biomarkers:
Expression
Mutation
CNA
Others
‹
KRAS mutation (239)
KRAS G12C (159)
NRAS mutation (125)
KRAS G12D (64)
KRAS G12V (36)
KRAS wild-type (26)
KRAS G13D (22)
KRAS G12R (18)
NRAS Q61K (15)
KRAS G12A (14)
HRAS mutation (11)
KRAS G12 (10)
NRAS Q61 (10)
NRAS wild-type (10)
HRAS G13R (10)
KRAS G12S (9)
NRAS Q61R (9)
KRAS G13 (8)
KRAS mutation + STK11 mutation (8)
KRAS Q61H (7)
KRAS exon 2 mutation (7)
NRAS G12D (7)
TP53 mutation + KRAS mutation (6)
KRAS G12C + STK11 mutation (5)
NRAS G12 (5)
NRAS G13 (5)
NRAS Q61L (5)
EGFR mutation + KRAS mutation (4)
KRAS A146 (4)
KRAS A59T (4)
KRAS Q61 (4)
NRAS Q61H (4)
NRAS mutation + BRAF mutation (4)
HRAS Q61L (4)
KRAS A146T (3)
KRAS G12C + TP53 mutation (3)
KRAS G12D + STK11 mutation (3)
KRAS Y96D (3)
KRAS Y96S (3)
FLT3 mutation + NRAS mutation (3)
NRAS A146T (3)
NRAS G13D (3)
NRAS G13N (3)
NRAS G13R (3)
NRAS Q61K + BRAF V600E (3)
NRAS exon 2 mutation (3)
NRAS exon 4 mutation (3)
HRAS G12S (3)
EGFR T790M + KRAS mutation (2)
EGFR V802I + KRAS mutation (2)
KEAP1 mutation + KRAS mutation (2)
KRAS A146V (2)
KRAS A59 (2)
KRAS A59S (2)
KRAS G12C + KEAP1 mutation (2)
KRAS G12D + KRAS G12V (2)
KRAS G13A (2)
KRAS G13C (2)
KRAS G13D + BRAF mutation (2)
KRAS K117 (2)
KRAS Q99L (2)
KRAS R68M (2)
KRAS exon 12 mutation (2)
KRAS exon 2 wild-type (2)
KRAS exon 3 mutation (2)
KRAS exon 4 mutation (2)
KRAS mutation + EGFR wild-type (2)
KRAS mutation + STK11 mutation + KEAP1 mutation (2)
KRAS mutation + TP53 wild-type (2)
PIK3CA mutation + KRAS mutation (2)
STK11 mutation + KEAP1 mutation + KRAS G12C (2)
EGFR mutation + NRAS Q61K (2)
NRAS A146 (2)
NRAS A59 (2)
NRAS G12C + BRAF mutation (2)
NRAS H117 (2)
NRAS exon 3 mutation (2)
HRAS G12C (2)
HRAS G12D (2)
HRAS G12V (2)
ALK rearrangement + EGFR D761N + KRAS V14I (1)
ALK rearrangement + KRAS mutation (1)
APC mutation + KRAS mutation (1)
ARID1A mutation+ KRAS G12C (1)
BRAF V600E + KRAS G12R (1)
DICER1 A1690Gfs*9 + DICER1 E1813Q + KRAS G12L (1)
EGFR T790M + KRAS G12V (1)
KIR2DS4 mutation + KRAS mutation (1)
KRAS G12A + BRAF D549N (1)
KRAS G12C + ATM wild-type (1)
KRAS G12C + KRAS G12V (1)
KRAS G12C + SMARCA4 wild-type (1)
KRAS G12D + DNMT3A C559fsX (1)
KRAS G12V + BRAF V600E (1)
KRAS G12V + STK11 mutation (1)
KRAS G12V + TP53 mutation + APC mutation (1)
KRAS G60D (1)
KRAS G61 (1)
KRAS G61H + KRAS G12A (1)
KRAS N116H (1)
KRAS N116T (1)
KRAS Q22X (1)
KRAS Q61K (1)
KRAS Q61L (1)
KRAS S89P (1)
KRAS V12 (1)
KRAS codon 12 mutation + KRAS codon 13 mutation + EGFR mutation (1)
KRAS exon 13 mutation (1)
KRAS mutation + ATM mutation (1)
KRAS mutation + KEAP1 mutation (1)
KRAS mutation + SMARCA4 mutation (1)
KRAS mutation + STK11 deletion + KEAP1 deletion (1)
KRAS mutation + STK11 mutation + TP53 mutation (1)
KRAS mutation + U2AF1 mutation (1)
KRAS mutation + KMT2C mutation (1)
MAP2K1 G128D + KRAS mutation (1)
MET exon 14 mutation + KRAS G12A (1)
NF1 L581Ffs*6 + KRAS A146P + NRAS Q61K + TP53 R175H + PD-L1 T290M (1)
PIK3CA mutation + PTEN mutation + KRAS mutation (1)
PIK3CA wild-type + KRAS wild-type (1)
PTPN11 mutation + KRAS wild-type (1)
STK11 mutation + KEAP1 mutation + KRAS wild-type (1)
ARAF mutation + NRAS mutation (1)
ASXL1 mutation + NRAS mutation (1)
BRAF wild-type + NRAS wild-type (1)
DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
DNMT3A mutation + NRAS mutation (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
FLT3 mutation + NRAS mutation + PTPN11 mutation (1)
FLT3-ITD mutation + ASXL1 mutation + NRAS mutation (1)
FLT3-ITD mutation + DNMT3A mutation + NRAS mutation (1)
FLT3-ITD mutation + NRAS mutation + GATA2 mutation (1)
FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
HRAS Q61L + NRAS Q61K (1)
IDH2 mutation + NRAS mutation (1)
NPM1 mutation + NRAS mutation (1)
NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
NRAS G115Efs*46 (1)
NRAS G12C + BRAF V600E + BRAF V600D (1)
NRAS G12S (1)
NRAS G12V (1)
NRAS G13D + BRAF V600E (1)
NRAS Q60H (1)
NRAS mutation + U2AF1 mutation (1)
SETBP1 mutation + NRAS mutation (1)
SRSF2 mutation + DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
TET2 mutation + NRAS mutation (1)
HRAS A146T (1)
HRAS H27_28fs* (1)
HRAS K117N (1)
HRAS Q61 (1)
HRAS Q61R (1)
HRAS G13R (1)
PIK3CA mutation + HRAS mutation (1)
BRAF V600E + KRAS G12D (0)
CDKN2A mutation + CDKN2B mutation + KRAS mutation (0)
CDKN2A mutation + KRAS mutation (0)
KRAS A146P (0)
KRAS A59 (0)
KRAS G61H (0)
KRAS mutation + TP53 mutation (0)
NRAS G12C (0)
HRAS wild-type (0)
KRAS mutation (239)
KRAS G12C (159)
NRAS mutation (125)
KRAS G12D (64)
KRAS G12V (36)
KRAS wild-type (26)
KRAS G13D (22)
KRAS G12R (18)
NRAS Q61K (15)
KRAS G12A (14)
HRAS mutation (11)
KRAS G12 (10)
NRAS Q61 (10)
NRAS wild-type (10)
HRAS G13R (10)
KRAS G12S (9)
NRAS Q61R (9)
KRAS G13 (8)
KRAS mutation + STK11 mutation (8)
KRAS Q61H (7)
KRAS exon 2 mutation (7)
NRAS G12D (7)
TP53 mutation + KRAS mutation (6)
KRAS G12C + STK11 mutation (5)
NRAS G12 (5)
NRAS G13 (5)
NRAS Q61L (5)
EGFR mutation + KRAS mutation (4)
KRAS A146 (4)
KRAS A59T (4)
KRAS Q61 (4)
NRAS Q61H (4)
NRAS mutation + BRAF mutation (4)
HRAS Q61L (4)
KRAS A146T (3)
KRAS G12C + TP53 mutation (3)
KRAS G12D + STK11 mutation (3)
KRAS Y96D (3)
KRAS Y96S (3)
FLT3 mutation + NRAS mutation (3)
NRAS A146T (3)
NRAS G13D (3)
NRAS G13N (3)
NRAS G13R (3)
NRAS Q61K + BRAF V600E (3)
NRAS exon 2 mutation (3)
NRAS exon 4 mutation (3)
HRAS G12S (3)
EGFR T790M + KRAS mutation (2)
EGFR V802I + KRAS mutation (2)
KEAP1 mutation + KRAS mutation (2)
KRAS A146V (2)
KRAS A59 (2)
KRAS A59S (2)
KRAS G12C + KEAP1 mutation (2)
KRAS G12D + KRAS G12V (2)
KRAS G13A (2)
KRAS G13C (2)
KRAS G13D + BRAF mutation (2)
KRAS K117 (2)
KRAS Q99L (2)
KRAS R68M (2)
KRAS exon 12 mutation (2)
KRAS exon 2 wild-type (2)
KRAS exon 3 mutation (2)
KRAS exon 4 mutation (2)
KRAS mutation + EGFR wild-type (2)
KRAS mutation + STK11 mutation + KEAP1 mutation (2)
KRAS mutation + TP53 wild-type (2)
PIK3CA mutation + KRAS mutation (2)
STK11 mutation + KEAP1 mutation + KRAS G12C (2)
EGFR mutation + NRAS Q61K (2)
NRAS A146 (2)
NRAS A59 (2)
NRAS G12C + BRAF mutation (2)
NRAS H117 (2)
NRAS exon 3 mutation (2)
HRAS G12C (2)
HRAS G12D (2)
HRAS G12V (2)
ALK rearrangement + EGFR D761N + KRAS V14I (1)
ALK rearrangement + KRAS mutation (1)
APC mutation + KRAS mutation (1)
ARID1A mutation+ KRAS G12C (1)
BRAF V600E + KRAS G12R (1)
DICER1 A1690Gfs*9 + DICER1 E1813Q + KRAS G12L (1)
EGFR T790M + KRAS G12V (1)
KIR2DS4 mutation + KRAS mutation (1)
KRAS G12A + BRAF D549N (1)
KRAS G12C + ATM wild-type (1)
KRAS G12C + KRAS G12V (1)
KRAS G12C + SMARCA4 wild-type (1)
KRAS G12D + DNMT3A C559fsX (1)
KRAS G12V + BRAF V600E (1)
KRAS G12V + STK11 mutation (1)
KRAS G12V + TP53 mutation + APC mutation (1)
KRAS G60D (1)
KRAS G61 (1)
KRAS G61H + KRAS G12A (1)
KRAS N116H (1)
KRAS N116T (1)
KRAS Q22X (1)
KRAS Q61K (1)
KRAS Q61L (1)
KRAS S89P (1)
KRAS V12 (1)
KRAS codon 12 mutation + KRAS codon 13 mutation + EGFR mutation (1)
KRAS exon 13 mutation (1)
KRAS mutation + ATM mutation (1)
KRAS mutation + KEAP1 mutation (1)
KRAS mutation + SMARCA4 mutation (1)
KRAS mutation + STK11 deletion + KEAP1 deletion (1)
KRAS mutation + STK11 mutation + TP53 mutation (1)
KRAS mutation + U2AF1 mutation (1)
KRAS mutation + KMT2C mutation (1)
MAP2K1 G128D + KRAS mutation (1)
MET exon 14 mutation + KRAS G12A (1)
NF1 L581Ffs*6 + KRAS A146P + NRAS Q61K + TP53 R175H + PD-L1 T290M (1)
PIK3CA mutation + PTEN mutation + KRAS mutation (1)
PIK3CA wild-type + KRAS wild-type (1)
PTPN11 mutation + KRAS wild-type (1)
STK11 mutation + KEAP1 mutation + KRAS wild-type (1)
ARAF mutation + NRAS mutation (1)
ASXL1 mutation + NRAS mutation (1)
BRAF wild-type + NRAS wild-type (1)
DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
DNMT3A mutation + NRAS mutation (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
FLT3 mutation + NRAS mutation + PTPN11 mutation (1)
FLT3-ITD mutation + ASXL1 mutation + NRAS mutation (1)
FLT3-ITD mutation + DNMT3A mutation + NRAS mutation (1)
FLT3-ITD mutation + NRAS mutation + GATA2 mutation (1)
FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
HRAS Q61L + NRAS Q61K (1)
IDH2 mutation + NRAS mutation (1)
NPM1 mutation + NRAS mutation (1)
NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
NRAS G115Efs*46 (1)
NRAS G12C + BRAF V600E + BRAF V600D (1)
NRAS G12S (1)
NRAS G12V (1)
NRAS G13D + BRAF V600E (1)
NRAS Q60H (1)
NRAS mutation + U2AF1 mutation (1)
SETBP1 mutation + NRAS mutation (1)
SRSF2 mutation + DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
TET2 mutation + NRAS mutation (1)
HRAS A146T (1)
HRAS H27_28fs* (1)
HRAS K117N (1)
HRAS Q61 (1)
HRAS Q61R (1)
HRAS G13R (1)
PIK3CA mutation + HRAS mutation (1)
BRAF V600E + KRAS G12D (0)
CDKN2A mutation + CDKN2B mutation + KRAS mutation (0)
CDKN2A mutation + KRAS mutation (0)
KRAS A146P (0)
KRAS A59 (0)
KRAS G61H (0)
KRAS mutation + TP53 mutation (0)
NRAS G12C (0)
HRAS wild-type (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
regorafenib
Sensitive: A1 - Approval
regorafenib
Sensitive
:
A1
regorafenib
Sensitive: A1 - Approval
regorafenib
Sensitive
:
A1
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
panitumumab
Sensitive: A1 - Approval
panitumumab
Sensitive
:
A1
panitumumab
Sensitive: A1 - Approval
panitumumab
Sensitive
:
A1
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
cetuximab
Sensitive: A2 - Guideline
cetuximab
Sensitive
:
A2
cetuximab
Sensitive: A2 - Guideline
cetuximab
Sensitive
:
A2
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
fruquintinib
Sensitive: B - Late Trials
fruquintinib
Sensitive
:
B
fruquintinib
Sensitive: B - Late Trials
fruquintinib
Sensitive
:
B
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
bevacizumab
Sensitive: B - Late Trials
bevacizumab
Sensitive
:
B
bevacizumab
Sensitive: B - Late Trials
bevacizumab
Sensitive
:
B
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
ramucirumab
Sensitive: C2 – Inclusion Criteria
ramucirumab
Sensitive
:
C2
ramucirumab
Sensitive: C2 – Inclusion Criteria
ramucirumab
Sensitive
:
C2
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
bevacizumab + cetuximab
Sensitive: C2 – Inclusion Criteria
bevacizumab + cetuximab
Sensitive
:
C2
bevacizumab + cetuximab
Sensitive: C2 – Inclusion Criteria
bevacizumab + cetuximab
Sensitive
:
C2
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
cetuximab + avelumab
Sensitive: C2 – Inclusion Criteria
cetuximab + avelumab
Sensitive
:
C2
cetuximab + avelumab
Sensitive: C2 – Inclusion Criteria
cetuximab + avelumab
Sensitive
:
C2
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
cetuximab + camrelizumab
Sensitive: C2 – Inclusion Criteria
cetuximab + camrelizumab
Sensitive
:
C2
cetuximab + camrelizumab
Sensitive: C2 – Inclusion Criteria
cetuximab + camrelizumab
Sensitive
:
C2
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
EGFR inhibitor
Sensitive: C3 – Early Trials
EGFR inhibitor
Sensitive
:
C3
EGFR inhibitor
Sensitive: C3 – Early Trials
EGFR inhibitor
Sensitive
:
C3
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
avelumab
Sensitive: C3 – Early Trials
avelumab
Sensitive
:
C3
avelumab
Sensitive: C3 – Early Trials
avelumab
Sensitive
:
C3
RAS wild-type
Colon Cancer
RAS wild-type
Colon Cancer
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
anlotinib
Sensitive: C3 – Early Trials
anlotinib
Sensitive
:
C3
anlotinib
Sensitive: C3 – Early Trials
anlotinib
Sensitive
:
C3
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
cetuximab + tislelizumab-jsgr
Sensitive: C3 – Early Trials
cetuximab + tislelizumab-jsgr
Sensitive
:
C3
cetuximab + tislelizumab-jsgr
Sensitive: C3 – Early Trials
cetuximab + tislelizumab-jsgr
Sensitive
:
C3
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
EGFR inhibitor + VEGF inhibitor
Sensitive: C3 – Early Trials
EGFR inhibitor + VEGF inhibitor
Sensitive
:
C3
EGFR inhibitor + VEGF inhibitor
Sensitive: C3 – Early Trials
EGFR inhibitor + VEGF inhibitor
Sensitive
:
C3
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
panitumumab + cabozantinib tablet
Sensitive: C3 – Early Trials
panitumumab + cabozantinib tablet
Sensitive
:
C3
panitumumab + cabozantinib tablet
Sensitive: C3 – Early Trials
panitumumab + cabozantinib tablet
Sensitive
:
C3
RAS wild-type
Colorectal Cancer
RAS wild-type
Colorectal Cancer
panitumumab + niraparib
Sensitive: C3 – Early Trials
panitumumab + niraparib
Sensitive
:
C3
panitumumab + niraparib
Sensitive: C3 – Early Trials
panitumumab + niraparib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
